Autologous Chimeric Switch Receptor Modified T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous Chimeric Switch Receptor Modified T Cells, covering 2016-10-19 to 2016-10-19. Get the full timeline:
Most recent: Clinical Trial Update: Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme [Phase 1]